ArticleCancers2023

Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301.

Byungho Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.